Trial watch: chemotherapy-induced immunogenic cell death in oncology

Immunogenic cell death (ICD) refers to an immunologically distinct process of regulated cell death that activates, rather than suppresses, innate and adaptive immune responses. Such responses culminate into T cell-driven immunity against antigens derived from dying cancer cells. The potency of ICD i...

وصف كامل

التفاصيل البيبلوغرافية
الحاوية / القاعدة:OncoImmunology
المؤلفون الرئيسيون: Jenny Sprooten, Raquel S. Laureano, Isaure Vanmeerbeek, Jannes Govaerts, Stefan Naulaerts, Daniel M. Borras, Lisa Kinget, Jitka Fucíková, Radek Špíšek, Lenka Palová Jelínková, Oliver Kepp, Guido Kroemer, Dmitri V. Krysko, An Coosemans, Rianne D.W. Vaes, Dirk De Ruysscher, Steven De Vleeschouwer, Els Wauters, Evelien Smits, Sabine Tejpar, Benoit Beuselinck, Sigrid Hatse, Hans Wildiers, Paul M. Clement, Peter Vandenabeele, Laurence Zitvogel, Abhishek D. Garg
التنسيق: مقال
اللغة:الإنجليزية
منشور في: Taylor & Francis Group 2023-12-01
الموضوعات:
CAR T cells, antigen-presenting cells
chemotherapy
danger signals
dendritic cell
immune-checkpoint blockers
immunogenic cell death
الوصول للمادة أونلاين:https://www.tandfonline.com/doi/10.1080/2162402X.2023.2219591

الانترنت

https://www.tandfonline.com/doi/10.1080/2162402X.2023.2219591

مواد مشابهة